...
首页> 外文期刊>BMC Infectious Diseases >Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
【24h】

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis

机译:原发性硬化性胆管炎合并持续胆道念珠菌病的危险因素和预后

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Candidiasis is commonly observed in patients with primary sclerosing cholangitis (PSC), but the clinical risk factors associated with its presence have not been fully investigated. In this study, we aimed to analyse the incidence, risk factors, and transplantation-free survival in primary sclerosing cholangitis (PSC) patients with persistent biliary candidiasis. Methods We retrospectively analysed patients diagnosed with PSC who were admitted to our department during 2002 to 2012. One-hundred fifty patients whose bile cultures were tested for fungal species were selected, and their clinical and laboratory parameters were investigated. The results of endoscopic retrograde cholangiography (ERC) and bile cultures were analysed using chart reviews. The cases of biliary candidiasis were sub-classified as transient or persistent. Results Thirty out of 150 (20.0%) patients had biliary candidiasis. Although all patients demonstrated comparable baseline characteristics, those with biliary candidiasis showed significantly reduced transplantation-free survival (p? Conclusions The persistence of biliary candidiasis is associated with markedly reduced transplantation-free survival in PSC patients. By contrast, actuarial survival in patients with transient biliary candidiasis approaches that for patients without any evidence of biliary candidiasis. Further studies on the treatment of persistent biliary candidiasis in patients with PSC are warranted.
机译:背景念珠菌病通常在原发性硬化性胆管炎(PSC)患者中观察到,但与其存在相关的临床危险因素尚未得到充分研究。在这项研究中,我们旨在分析患有顽固性胆管念珠菌病的原发性硬化性胆管炎(PSC)患者的发生率,危险因素和无移植生存。方法回顾性分析2002年至2012年入院的确诊为PSC的患者。选择一百五十例经胆汁培养检测真菌种类的患者,并对其临床和实验室参数进行调查。内镜逆行胆管造影(ERC)和胆汁培养的结果使用图表审查进行了分析。胆道念珠菌病被分为暂时性或持续性。结果150名患者中有30名(20.0%)患有胆道念珠菌病。尽管所有患者均表现出可比的基线特征,但胆道念珠菌病患者的无移植生存期明显降低(p?结论结论PSC患者胆道念珠菌病的持续存在与无移植生存期显着降低有关。对于没有任何胆道念珠菌病证据的患者而言,胆道念珠菌病的治疗方法值得进一步研究,以治疗PSC患者持续性胆道念珠菌病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号